Literature DB >> 26150375

The Impact of Colleague Peer Review on the Radiotherapy Treatment Planning Process in the Radical Treatment of Lung Cancer.

K P Rooney1, J McAleese2, C Crockett2, J Harney2, R L Eakin2, V A L Young2, M A Dunn2, R E Johnston2, G G Hanna3.   

Abstract

AIMS: Modern radiotherapy uses techniques to reliably identify tumour and reduce target volume margins. However, this can potentially lead to an increased risk of geographic miss. One source of error is the accuracy of target volume delineation (TVD). Colleague peer review (CPR) of all curative-intent lung cancer plans has been mandatory in our institution since May 2013. At least two clinical oncologists review plans, checking treatment paradigm, TVD, prescription dose tumour and critical organ tolerances. We report the impact of CPR in our institution.
MATERIALS AND METHODS: Radiotherapy treatment plans of all patients receiving radical radiotherapy were presented at weekly CPR meetings after their target volumes were reviewed and signed off by the treating consultant. All cases and any resultant change to TVD (including organs at risk) or treatment intent were recorded in our prospective CPR database. The impact of CPR over a 13 month period from May 2013 to June 2014 is reported.
RESULTS: One hundred and twenty-two patients (63% non-small cell lung carcinoma, 17% small cell lung carcinoma and 20% 'clinical diagnosis') were analysed. On average, 3.2 cases were discussed per meeting (range 1-8). CPR resulted in a change in treatment paradigm in 3% (one patient proceeded to induction chemotherapy, two patients had high-dose palliative radiotherapy). Twenty-one (17%) had a change in TVD and one (1%) patient had a change in dose prescription. In total, 6% of patients had plan adjustment after review of dose volume histogram.
CONCLUSION: The introduction of CPR in our centre has resulted in a change in a component of the treatment plan for 27% of patients receiving curative-intent lung radiotherapy. We recommend CPR as a mandatory quality assurance step in the planning process of all radical lung plans.
Copyright © 2015 The Royal College of Radiologists. Published by Elsevier Ltd. All rights reserved.

Entities:  

Keywords:  Non-small cell lung cancer; peer review; quality assurance; radiotherapy; target volume delineation

Mesh:

Year:  2015        PMID: 26150375     DOI: 10.1016/j.clon.2015.05.010

Source DB:  PubMed          Journal:  Clin Oncol (R Coll Radiol)        ISSN: 0936-6555            Impact factor:   4.126


  7 in total

Review 1.  Challenges in the target volume definition of lung cancer radiotherapy.

Authors:  Susan Mercieca; José S A Belderbos; Marcel van Herk
Journal:  Transl Lung Cancer Res       Date:  2021-04

2.  Reply: Comment on 'KRAS and BRAF mutations are prognostic biomarkers in patients undergoing lung metastasectomy of colo-rectal cancer'.

Authors:  Stéphane Renaud; Pierre-Emmanuel Falcoz; Benoit Romain; Anne Olland; Nicola Santelmo; Cécile Brigand; Serge Rohr; Dominique Guenot; Gilbert Massard
Journal:  Br J Cancer       Date:  2015-09-15       Impact factor: 7.640

3.  Early circulating tumour DNA kinetics measured by ultra-deep next-generation sequencing during radical radiotherapy for non-small cell lung cancer: a feasibility study.

Authors:  G M Walls; L McConnell; J McAleese; P Murray; T B Lynch; K Savage; G G Hanna; D Gonzalez de Castro
Journal:  Radiat Oncol       Date:  2020-05-29       Impact factor: 3.481

4.  The Impact of Transitioning to Prospective Contouring and Planning Rounds as Peer Review.

Authors:  Murat Surucu; Amishi Bajaj; John C Roeske; Alec M Block; Jennifer Price; William Small; Abhishek A Solanki
Journal:  Adv Radiat Oncol       Date:  2019-03-21

Review 5.  Practical implications to contemplate when considering radical therapy for stage III non-small-cell lung cancer.

Authors:  Claire L Storey; Gerard G Hanna; Alastair Greystoke
Journal:  Br J Cancer       Date:  2020-12       Impact factor: 7.640

Review 6.  Cancer Stem Cells: The Potential Targets of Chinese Medicines and Their Active Compounds.

Authors:  Ming Hong; Hor Yue Tan; Sha Li; Fan Cheung; Ning Wang; Tadashi Nagamatsu; Yibin Feng
Journal:  Int J Mol Sci       Date:  2016-06-07       Impact factor: 5.923

Review 7.  Spontaneous regression of ALK fusion protein-positive non-small cell lung carcinoma: a case report and review of the literature.

Authors:  Maria Walls; Gerard M Walls; Jacqueline A James; Kyle T Crawford; Hossam Abdulkhalek; Tom B Lynch; Aaron J Peace; Terry E McManus; O Rhun Evans
Journal:  BMC Pulm Med       Date:  2020-08-06       Impact factor: 3.317

  7 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.